Many hopes have been pinned on repurposing existing drugs, such as ivermectin and hydroxychloroquine, to treat COVID-19. However, we shouldn't be too surprised these drugs haven't yet lived up to the hype.
Sep 23, 2021
0
10
A Purdue University engineer's patent-pending invention could improve the quality of life for millions of people suffering from diabetic foot ulcers.
Sep 16, 2021
0
6
(HealthDay)—The highly transmissible Delta variant of COVID-19 has highlighted a fear shared by infectious disease experts worldwide: That increasingly dangerous mutations will continue to crop up until most people around ...
Sep 8, 2021
0
10
A new paper co-written by a University of Illinois Urbana-Champaign scholar who studies the legal and ethical implications of advanced biotechnologies outlines an unexplored tool to regulate the medically and ethically dubious ...
Aug 31, 2021
0
28
It's long been known that correctly timing an embryo transfer is critical to the chance of achieving pregnancy.
Aug 24, 2021
0
233
A simple addition to injected COVID-19 vaccines could enhance their effectiveness and provide "border protection" immunity in areas like the nose and mouth to supplement antibodies in the bloodstream, new research suggests.
Aug 11, 2021
0
382
(HealthDay)—Polygenic variants are associated with comparable risk for developing open-angle glaucoma as that associated with the most common single-gene pathogenic variant, according to a study published online July 15 ...
Jul 23, 2021
0
2
The World Health Organization on Wednesday sought to reassure pharmaceutical companies that a proposal to suspend patent rights on COVID-19 vaccines was not a bid to "snatch" their intellecutual property rights.
Jul 22, 2021
0
1
In pharmaceutical research, small tissue spheres are used as mini-organ models for reproducible tests. TU Wien has found a way to develop a reliable standard for these tissue samples.
May 26, 2021
0
326
The European Parliament has urged the EU to back a push for a temporary waiver of coronavirus vaccine patents, in the face of scepticism from Brussels and key member states.
May 20, 2021
0
9
